Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical experience with MultiHance in CNS imaging.

M Essig1

  • 1German Cancer Research Center, Heidelberg, Germany.

European Radiology
|March 16, 2004
PubMed
Summary

This review examines the clinical utility of the contrast agent Gd-BOPTA in central nervous system imaging. It highlights how this agent enhances the visibility of brain and spinal cord lesions, improves diagnostic accuracy, and optimizes specialized imaging techniques like perfusion scans.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Perfusion MRI in CNS disease: current concepts.

Neuroradiology·2020
Same author

Predicting Motor Outcome in Acute Intracerebral Hemorrhage.

AJNR. American journal of neuroradiology·2019
Same author

Structural patterns of the human ABCC4/MRP4 exporter in lipid bilayers rationalize clinically observed polymorphisms.

Pharmacological research·2018
Same author

Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Uterus transplantation in France: for which patients?

European journal of obstetrics, gynecology, and reproductive biology·2016
Same author

High-grade glioma management and response assessment-recent advances and current challenges.

Current oncology (Toronto, Ont.)·2016

Area of Science:

  • Diagnostic radiology and Gd-BOPTA applications within clinical neuroscience
  • Medical imaging technology and contrast agent pharmacology

Background:

Current diagnostic protocols for central nervous system disorders often struggle to achieve optimal lesion visualization using standard contrast media. This gap motivated researchers to evaluate alternative agents with superior pharmacological profiles. Prior studies have established that conventional gadolinium compounds possess limitations in both sensitivity and signal enhancement. That uncertainty drove the exploration of agents with higher relaxivity properties to improve image quality. It was already known that morphological assessments require high-contrast resolution for accurate clinical decision-making. No prior work had resolved the full extent of diagnostic improvements offered by newer agents in routine practice. This review addresses how specific chemical properties translate into better patient outcomes during neurological examinations. The literature suggests that enhancing signal intensity remains a primary objective for improving diagnostic confidence in complex cases.

Purpose Of The Study:

Keywords:
contrast mediamagnetic resonance imagingneurological diagnosisradiology enhancement

Frequently Asked Questions

The researchers propose that Gd-BOPTA increases signal intensity through higher relaxivity. This property allows for clearer visualization of lesions compared to standard gadolinium-based agents, which often exhibit lower contrast enhancement in neurological scans.

The authors identify perfusion magnetic resonance imaging and dynamic angiographic protocols as key beneficiaries. These specialized techniques rely on the agent's ability to provide rapid, high-quality signal changes during dynamic data acquisition.

The authors state that higher relaxivity is necessary to achieve the observed improvements in functional imaging. This physical property ensures that the contrast agent remains visible during rapid physiological processes, unlike conventional options.

The authors utilize clinical literature to assess the role of morphological data in patient diagnosis. This information helps clinicians distinguish between various pathologies, thereby improving the overall accuracy of the differential diagnostic process.

Related Experiment Videos

The aim of this review is to evaluate the clinical experience and diagnostic utility of Gd-BOPTA in central nervous system imaging. This study addresses the need to understand how advanced contrast agents impact the accuracy of neurological diagnoses. The researchers seek to clarify the relationship between pharmacological properties and image quality in clinical practice. They investigate whether superior signal enhancement leads to better lesion detection compared to traditional methods. The motivation stems from the desire to optimize both morphological and functional imaging protocols for complex brain and spinal cord cases. The authors examine how these improvements influence the daily workflow of radiologists and clinicians. By synthesizing available evidence, the study clarifies the benefits of adopting high-relaxivity agents in modern neuroimaging. This work provides a foundation for understanding the clinical value of specialized contrast media in diagnostic settings.

Main Methods:

Review Approach involves a comprehensive synthesis of existing clinical data regarding contrast-enhanced magnetic resonance scans. The authors examined literature focusing on the diagnostic efficacy of newer agents versus standard options. They evaluated performance metrics across various neurological conditions to determine the impact on image quality. The analysis prioritized studies that utilized both morphological and functional assessment techniques. Researchers compared signal enhancement capabilities to identify potential advantages in clinical workflows. They synthesized findings from multiple trials to characterize the utility of the agent in diverse patient populations. The approach focused on identifying how pharmacological differences influence the accuracy of radiological interpretations. This methodology ensures a broad overview of the current evidence base supporting advanced neuroimaging practices.

Main Results:

Key Findings From the Literature demonstrate that Gd-BOPTA significantly improves the detection and delineation of central nervous system lesions. The evidence indicates that this agent outperforms conventional gadolinium-based options in providing clearer diagnostic information. The literature reports that clinicians achieve higher levels of diagnostic confidence when utilizing this specific contrast medium. Findings suggest that the higher relaxivity of the agent is a key factor in optimizing functional imaging studies. Data show that perfusion magnetic resonance imaging benefits from the enhanced signal characteristics provided by the compound. The results confirm that dynamic angiographic protocols are more effective when using this agent for vascular visualization. The synthesis indicates that the differential diagnostic process is substantially improved through these enhanced imaging capabilities. These results collectively highlight the clinical advantages of transitioning to agents with superior pharmacological profiles for neurological examinations.

Conclusions:

Synthesis and Implications indicate that Gd-BOPTA provides superior diagnostic performance for central nervous system imaging compared to traditional agents. The authors suggest that higher relaxivity values directly translate into more reliable lesion detection. Clinical evidence supports the use of this agent to refine differential diagnostic pathways for neurological patients. The review highlights how improved image quality facilitates greater confidence among radiologists during routine assessments. Specialized protocols, including perfusion imaging, benefit significantly from the unique pharmacological characteristics of this contrast medium. The synthesis confirms that morphological and functional data acquisition is optimized through these specific chemical enhancements. These findings imply that adopting such agents could streamline clinical workflows in neuroimaging centers. The authors conclude that the agent represents a valuable tool for modern diagnostic environments.

The researchers measure diagnostic confidence as a primary outcome. They observe that clinicians report higher certainty when interpreting images enhanced with this agent versus those obtained using traditional contrast media.

The authors claim that the agent facilitates a more robust differential diagnostic process. They suggest this shift allows for faster and more accurate identification of central nervous system conditions in clinical settings.